$11.37
+0.27 (+2.43%)
Open$11.23
Previous Close$11.10
Day High$11.60
Day Low$11.05
52W High$16.10
52W Low$5.30
Volume—
Avg Volume21.6K
Market Cap1.92M
P/E Ratio—
EPS$-4.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
-14.5% upside
Current
$11.37
$11.37
Target
$9.72
$9.72
$6.32
$9.72 avg
$10.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 493.3K | 481.3K | 473.6K |
| Net Income | 115.4K | 80.6K | 101.2K |
| Profit Margin | 23.4% | 16.8% | 21.4% |
| EBITDA | 189.6K | 155.0K | 161.9K |
| Free Cash Flow | 102.8K | 100.3K | 125.4K |
| Rev Growth | +17.7% | -1.9% | +10.9% |
| Debt/Equity | 0.11 | 0.15 | 0.11 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |